We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $256M
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
-15.3%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$20B
AUM Growth
-$4.58B
Cap. Flow
-$205M
Cap. Flow %
-1.03%
Top 10 Hldgs %
18.75%
Holding
1,300
New
139
Increased
450
Reduced
467
Closed
138

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$62M
2
AAPL icon
Apple
AAPL
+$59.4M
3
ZBH icon
Zimmer Biomet
ZBH
+$42M
4
ADBE icon
Adobe
ADBE
+$38.6M
5
JNJ icon
Johnson & Johnson
JNJ
+$38.2M

Top Sells

Rank Stock Value
1
EBAY icon
eBay
EBAY
+$58.6M
2
V icon
Visa
V
+$48.9M
3
CHTR icon
Charter Communications
CHTR
+$44.5M
4
KKR icon
KKR & Co
KKR
+$43.8M
5
FIS icon
Fidelity National Information Services
FIS
+$37.8M

Sector Composition

Rank Sector Weight
1 Technology 26.35%
2 Healthcare 19.06%
3 Financials 10.37%
4 Consumer Discretionary 10.34%
5 Industrials 6.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCO icon
76
Moody's
MCO
$84.6B
$62.4M 0.31%
295,150
+136,044
+86% +$33.1M
EQIX icon
77
Equinix
EQIX
$101B
$60.8M 0.3%
97,305
+33,199
+52% +$19.9M
ILMN icon
78
Illumina
ILMN
$29.6B
$60.6M 0.3%
228,096
-23,080
-9% -$6.45M
IBM icon
79
IBM
IBM
$217B
$60.4M 0.3%
569,897
+86,989
+18% +$11M
ALXN
80
DELISTED
Alexion Pharmaceuticals
ALXN
$59.9M 0.3%
667,327
-24,355
-4% -$2.39M
MMM icon
81
3M
MMM
$92.4B
$58.8M 0.29%
514,940
+68,767
+15% +$9.05M
BIIB icon
82
Biogen
BIIB
$30.6B
$58.6M 0.29%
185,360
+5
+0% +$1.52K
KMB icon
83
Kimberly-Clark
KMB
$37.4B
$58.6M 0.29%
457,986
+214,985
+88% +$29.7M
GMED icon
84
Globus Medical
GMED
$11.1B
$58.5M 0.29%
1,374,710
+154,586
+13% +$7.64M
SYK icon
85
Stryker
SYK
$135B
$58.3M 0.29%
350,103
-3,966
-1% -$775K
MDLZ icon
86
Mondelez International
MDLZ
$83.4B
$56.4M 0.28%
1,125,920
+108,477
+11% +$5.88M
AMH icon
87
American Homes 4 Rent
AMH
$12.1B
$55.5M 0.28%
2,394,025
+248,373
+12% +$6.56M
DHR icon
88
Danaher
DHR
$139B
$55.4M 0.28%
451,544
-171,007
-27% -$23M
BAC icon
89
Bank of America
BAC
$434B
$54.5M 0.27%
2,569,206
-242,237
-9% -$7.26M
ELV icon
90
Elevance Health
ELV
$82.2B
$54.4M 0.27%
239,794
+37,062
+18% +$10.1M
TSM icon
91
TSMC
TSM
$2.02T
$54.3M 0.27%
1,135,769
+221,387
+24% +$12.1M
CGNX icon
92
Cognex
CGNX
$9.82B
$53.8M 0.27%
1,275,052
-101,964
-7% -$5.11M
MSCI icon
93
MSCI
MSCI
$42.6B
$53.7M 0.27%
185,806
+6,166
+3% +$1.75M
NUVA
94
DELISTED
NuVasive, Inc.
NUVA
$53.6M 0.27%
1,057,436
+65,674
+7% +$4.4M
BLK icon
95
Blackrock
BLK
$171B
$52.8M 0.26%
119,922
+35,956
+43% +$17.7M
NXPI icon
96
NXP Semiconductors
NXPI
$63.6B
$51.6M 0.26%
622,636
-33,244
-5% -$3.9M
ATVI
97
DELISTED
Activision Blizzard
ATVI
$51.3M 0.26%
861,669
-249,085
-22% -$14.8M
CL icon
98
Colgate-Palmolive
CL
$74.6B
$51M 0.25%
768,417
+188,515
+33% +$13.3M
BMY icon
99
Bristol-Myers Squibb
BMY
$130B
$50.7M 0.25%
909,036
-460,965
-34% -$28.2M
UNP icon
100
Union Pacific
UNP
$174B
$49.9M 0.25%
353,838
+7,973
+2% +$1.32M

Similar funds

Axa's Q1 2020 Portfolio in Review

As of Q1 2020, Axa held 1,300 positions worth $20B, down 19% from $24.6B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Axa's Q1 2020 filing shows 139 new, 450 increased, 467 reduced and 138 closed positions. Its largest new stake was Axonics, Inc. Common Stock: 924,400 shares worth $23.5M. The largest sale was eBay, an estimated $58.6M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.

  • Axa's largest Q1 2020 buy was Axonics, Inc. Common Stock: 924,400 shares worth $23.5M.
  • Axa added most to Alphabet (Google) Class A in Q1 2020, an estimated $62M increase.
  • Axa's biggest Q1 2020 reduction was eBay, cutting an estimated $58.6M.
  • Axa fully exited KKR & Co in Q1 2020, selling an estimated $43.8M.
  • Axa's ten largest holdings make up 19% of its $20B portfolio in Q1 2020.
  • Axa opened 139 new positions and closed 138 in Q1 2020.
  • Axa's portfolio value fell 19% quarter-over-quarter to $20B.

Based on Axa's 13F filing for Q1 2020, filed 15 May 2020.